Cargando…
An Exploratory Analysis of the Association Between Catechol-O-Methyltransferase and Response to a Randomized Open-Label Placebo Treatment for Cancer-Related Fatigue
Previous studies have identified catechol-O-methyltransferase (COMT), as a key enzyme influencing sympathetic function. Although the COMT SNP rs4680 and rs4818, are well-studied, little is known about their influence on cancer-related fatigue (CrF) and placebo response. In this study, we examined wh...
Autores principales: | Hoenemeyer, Teri W., Baidwan, Navneet Kaur, Hall, Kathryn, Kaptchuk, Ted J., Fontaine, Kevin R., Mehta, Tapan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275998/ https://www.ncbi.nlm.nih.gov/pubmed/34267689 http://dx.doi.org/10.3389/fpsyt.2021.684556 |
Ejemplares similares
-
Open-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial
por: Hoenemeyer, Teri W., et al.
Publicado: (2018) -
Catechol-O-Methyltransferase moderates effect of stress mindset on affect and cognition
por: Crum, Alia J., et al.
Publicado: (2018) -
Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome
por: Hall, Kathryn T., et al.
Publicado: (2016) -
Correction: Catechol-O-Methyltransferase moderates effect of stress mindset on affect and cognition
por: Crum, Alia J., et al.
Publicado: (2019) -
Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome
por: Hall, Kathryn T., et al.
Publicado: (2012)